Wells Fargo’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6 Buy
+2
New +$8 ﹤0.01% 7181
2026
Q2
– Sell
-6,282
Closed -$24.1K – 7515
2026
Q1
$24.1K Sell
6,282
-11,989
-66% -$49.1K ﹤0.01% 5703
2025
Q4
$67.8K Buy
18,271
+6,632
+57% +$56.9K ﹤0.01% 5498
2025
Q3
$164K Buy
11,639
+1,129
+11% +$17.6K ﹤0.01% 5049
2025
Q2
$202K Buy
+10,510
New +$164K ﹤0.01% 4763
2024
Q4
– Sell
-1
Closed -$7 – 7160
2024
Q3
$7 Hold
1
– – ﹤0.01% 6721
2024
Q2
$42 Sell
1
-1,058
-100% -$51.8K ﹤0.01% 6347
2024
Q1
$35.3K Sell
1,059
-3,102
-75% -$157K ﹤0.01% 5388
2023
Q4
$338K Sell
4,161
-156
-4% -$12.7K ﹤0.01% 4136
2023
Q3
$705K Sell
4,317
-911
-17% -$215K ﹤0.01% 3553
2023
Q2
$1.71M Buy
5,228
+533
+11% +$163K ﹤0.01% 3039
2023
Q1
$1.3M Buy
4,695
+868
+23% +$319K ﹤0.01% 3198
2022
Q4
$1.48M Sell
3,827
-648
-14% -$183K ﹤0.01% 2988
2022
Q3
$1.07M Sell
4,475
-401
-8% -$107K ﹤0.01% 3196
2022
Q2
$1.09M Sell
4,876
-6,866
-58% -$2.95M ﹤0.01% 3242
2022
Q1
$8M Buy
11,742
+29
+0.2% +$17.4K ﹤0.01% 2040
2021
Q4
$8.1M Sell
11,713
-128,416
-92% -$95M ﹤0.01% 2047
2021
Q3
$104M Buy
140,129
+56,697
+68% +$38.6M 0.02% 636
2021
Q2
$62.5M Buy
83,432
+55,844
+202% +$42.7M 0.01% 932
2021
Q1
$22.5M Buy
27,588
+16,930
+159% +$13.1M 0.01% 1588
2020
Q4
$9.09M Buy
10,658
+322
+3% +$248K ﹤0.01% 2161
2020
Q3
$7.75M Buy
+10,336
New +$8.49M ﹤0.01% 2097

Other funds holding OM

Wells Fargo's OM Position: Q3 2026 in Review

Wells Fargo opened a new position in Outset Medical (OM) in Q3 2026: 2 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #7181 among its holdings. This is a return to the name: Wells Fargo previously reported a position in OM as recently as Q1 2026.

Wells Fargo first reported a position in OM in Q3 2020 and has held it in 22 quarters since. The position peaked at $104M in Q3 2021. 77 funds tracked by Wall St. Rank hold OM as of Q3 2026.

  • Wells Fargo held 2 shares of Outset Medical worth $6 as of Q3 2026.
  • Outset Medical was a new Wells Fargo position in Q3 2026.
  • Outset Medical made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #7181 holding.
  • Wells Fargo first reported a position in Outset Medical in Q3 2020 and has held it in 22 quarters since.
  • Wells Fargo's Outset Medical position peaked at $104M in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Outset Medical as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.